No price series to chart for ABPWW.
ABPWW is not in the screener universe; fundamentals are unavailable.
No price history for ABPWW — it is outside the redistributable backbone (BYOK data required), so price statistics are unavailable.
No return history for ABPWW, so risk analytics are unavailable.
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| AMGN | AMGEN INC | $209.21B | 27.2 |
| GILD | GILEAD SCIENCES, INC. | $162.99B | 19.4 |
| RVMD | Revolution Medicines, Inc. | $40.85B | — |
| BIIB | BIOGEN INC. | $30.70B | 23.7 |
| MRNA | Moderna, Inc. | $22.98B | — |
| NBIX | NEUROCRINE BIOSCIENCES INC | $18.65B | 39.7 |
| EXEL | EXELIXIS, INC. | $14.07B | 31.8 |
| TECH | BIO-TECHNE Corp | $11.28B | 156.6 |
| KRYS | Krystal Biotech, Inc. | $10.81B | 53.6 |
| HALO | HALOZYME THERAPEUTICS, INC. | $9.88B | 32.5 |
| QGEN | QIAGEN N.V. | $8.99B | — |
| KYMR | Kymera Therapeutics, Inc. | $8.80B | — |